BSJ-03-204
Based on 1 Customer Validation
BSJ-03-204 is a PROTAC-based CDK degrader derived from Palbociclib (HY-50767). BSJ-03-204 targets bovine CDK4/CCND1 and CDK6/CCND1 complexes with IC50 values of 26.9 nM and 10.4 nM, respectively. BSJ-03-204 also triggers ubiquitination and degradation of RB1, reduces pRb levels, thereby inducing G1 cell cycle arrest and exerting antiproliferative effects, as well as inducing time-dependent KLHL8 accumulation. BSJ-03-204 can be used in research related to pancreatic ductal adenocarcinoma, breast cancer, lung cancer, mantle cell lymphoma, and cloned bovine placental hyperplasia.
(Pink: ligand (HY-50767); Blue: Cereblon ligand (HY-103596); Black: linker (HY-W007803)).
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度 : 99.76%
- CAS 番号: 2349356-09-6
- 分子式: C43H48N10O8
- 分子量:832.90
-
保管条件:
-20°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
-
溶剤 & 溶解度
- プロトコル
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
-
HY-111556
BSJ-03-123CDK6 PROTAC Degrader -
HY-136252
BSJ-04-132PROTAC CDK4 Degrader -
HY-123937
THAL-SNS-032CDK9 PROTAC Degrader -
HY-130665
TL12-186Multi-Kinase PROTAC Degrader -
HY-50856
RuxolitinibJAK1/2 Inhibitor -
HY-138946
XY028-140CDK4/6 PROTAC -
HY-111519
dTRIM24PROTAC TRIM24 Degrader -
HY-111518
JH-XI-10-02PROTAC CDK8 Degrader -
HY-129180
XY028-133CDK4/6 PROTAC Degrader
PROTACs アイソフォーム固有の製品をすべて表示
More
生物活性
製品説明
IC50 & Target
[1]|
Cdk4/cyclin D1 26.9 nM (IC50) |
CDK6/cyclinD1 10.4 nM (IC50) |
MCE検証データ
体外実験
BSJ-03-204 (0.02-20 μM; 1 h) induces degradation of CDK4 and CDK6 at lower concentrations and stabilizes them at 20 μM in intact K562 cells. It also stabilizes CRBN, FECH, HNRNPDL, HNRNPUL1, PIP4K2A, PLK1, TIA1 and TIAL1, and destabilizes RB1, with EC50 values ranging from 1.1 μM to 14.4 μM[1].
BSJ-03-204 (0.1-0.2 μM; 18-48 h) mediates the degradation of CDK4 and CDK6 in 1222 pancreatic ductal adenocarcinoma (PDAC) cells; at 18 h, it exhibits stronger activity against CDK4 than Palbo-PROTAC, while at 48 h, its degradative effect persists but is less potent than that of BSJ-02-162[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:PDAC 1222 cells
-
Concentration:0.1-0.2 μM (18 h incubation); 0.1-0.2 μM (48 h incubation)
-
Incubation Time:18 h; 48 h
-
Result:Degraded CDK4 and CDK6 after 18 h incubation, showing greater potency for CDK4 degradation compared to Palbo-PROTAC.
Continued to degrade CDK4 and CDK6 after 48 h incubation, though exhibited less potency than BSJ-02-162 for degrading both kinases.
-
Cell Line:Granta-519 mantle cell lymphoma (MCL) cells
-
Concentration:1 µM
-
Incubation Time:1 day
-
Result:Induced pronounced loss of CDK4 and CDK6 protein levels.
Reduced levels of phosphorylated retinoblastoma (Rb).
Potently induced G1 cell cycle arrest.
化学情報
-
CAS 番号 2349356-09-6
-
性状 Solid
-
分子量 832.90
-
分子式 C43H48N10O8
-
Color Light yellow to yellow
-
SMILES
O=C1N(C2CCCC2)C3=NC(NC4=CC=C(N(CC5)CCN5CCCCNC(COC6=C(C(N7C(CCC8=O)C(N8)=O)=O)C(C7=O)=CC=C6)=O)C=N4)=NC=C3C(C)=C1C(C)=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
-20°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
溶剤 & 溶解度
体外:
DMSO : 100 mg/mL (120.06 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
体内:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
純度とドキュメンテーション
-
データシート (283 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
取扱説明書 (2659 KB)
参考文献
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.2006 mL | 6.0031 mL | 12.0062 mL | 30.0156 mL |
| 5 mM | 0.2401 mL | 1.2006 mL | 2.4012 mL | 6.0031 mL | |
| 10 mM | 0.1201 mL | 0.6003 mL | 1.2006 mL | 3.0016 mL | |
| 15 mM | 0.0800 mL | 0.4002 mL | 0.8004 mL | 2.0010 mL | |
| 20 mM | 0.0600 mL | 0.3002 mL | 0.6003 mL | 1.5008 mL | |
| 25 mM | 0.0480 mL | 0.2401 mL | 0.4802 mL | 1.2006 mL | |
| 30 mM | 0.0400 mL | 0.2001 mL | 0.4002 mL | 1.0005 mL | |
| 40 mM | 0.0300 mL | 0.1501 mL | 0.3002 mL | 0.7504 mL | |
| 50 mM | 0.0240 mL | 0.1201 mL | 0.2401 mL | 0.6003 mL | |
| 60 mM | 0.0200 mL | 0.1001 mL | 0.2001 mL | 0.5003 mL | |
| 80 mM | 0.0150 mL | 0.0750 mL | 0.1501 mL | 0.3752 mL | |
| 100 mM | 0.0120 mL | 0.0600 mL | 0.1201 mL | 0.3002 mL |
BSJ-03-204 関連分類
HY-136250 関連分類
Powered by Bioz